Navigation Links
GenWay Biotech Appoints New Vice President Custom Laboratory Services
Date:5/8/2013

SAN DIEGO, May 8, 2013 /PRNewswire-iReach/ -- GenWay Biotech today announced the appointment of Michael Dale as the Company's new Vice President of Custom Laboratory Services. In this role, Mr. Dale will be responsible for providing leadership for GenWay Biotech Custom Services operations and business development initiatives.

"As a key member of the GenWay Biotech senior management team, Mr. Dale brings a wealth of experience and talent to his new role," commented Thomas Silberg , President and CEO of GenWay Biotech. "We look forward to Mr. Dale's leadership and insights to further improve our processes and programs as we endeavor to always provide the utmost quality for our customers."

Mr. Dale brings over thirty years of experience in the biotech industry with a reputation as a resourceful, hands-on leader with proven ability to identify and realize potential in markets, organizations, and people. His experience and knowledge working with limited resources and managing lean operations has enabled the success of several biotech and biomedical start-ups and small to mid-size organizations. Mr. Dale has held executive positions at organizations such as HTI Bio-Products, HTI Bio-Services, Vet-Stem, and Strategic BioSolutions. He holds a Bachelor degree in Business Administration from the Christian Heritage College.

"I am excited to leverage my previous years of experience in custom antibody and contract laboratory at Genway Biotech," stated Michael Dale . "For over 25 years, Genway Biotech has gained an outstanding reputation for providing quality products and services to thousands of diagnostic, pharmaceutical and academia customers. I am privileged to be part of this experienced team, and have the opportunity to help further develop the capabilities, processes and rising stature of the Company.

About GenWay Biotech, Inc.

Since 1998, GenWay Biotech has provided the diagnostic and research communities with thousands of specialty reagents and assays with unmatched quality workmanship at competitive prices. The company is recognized as a trusted out-sourcing partner throughout the world. The Company is comprised of three divisions including the catalog products and custom services divisions focused on protein and antibody solutions, and the FirstMark division focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. GenWay's headquarters are located in the heart of San Diego's biotech community in the Sorrento Valley/Mesa area. For additional information, please visit GenWayBio.com.


Media Contact:

Robert Gans GenWay Biotech, 858-458-0866, rgans@genwaybio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE GenWay Biotech
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Plandai Biotechnology, Inc. Announces Formation Of New Entity To Develop Pharmaceutical Applications
3. Increased Dosage of Needle-Free Erectile Dysfunction Medication TriMix-gel Now Available through KRS Global Biotechnology
4. Frost & Sullivan: Pharma and Biotech Industries Headed Toward an Era of Reduced Profit Margins
5. XBiotech to Present at UBS Global Healthcare Conference
6. TriMix Laboratories Announces New TriMix-gel Partnership with KRS Global Biotechnology
7. Immune Pharmaceuticals CEO to Chair BIO International Panel "Can Israel Become the Next Biotech Startup Nation?"
8. Biotech industry has "implementation gap" around demonstrating the value of products under development
9. George Rosenkranz to Receive 2013 Biotechnology Heritage Award
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Prodigy Diabetes Care and OK Biotech Align Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):